157 related articles for article (PubMed ID: 30483077)
1. Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model.
Kang S; Ha S; Park H; Nam E; Suh WH; Suh YH; Chang KA
Front Behav Neurosci; 2018; 12():273. PubMed ID: 30483077
[TBL] [Abstract][Full Text] [Related]
2. Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model.
Kim J; Kang S; Chang KA
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142509
[TBL] [Abstract][Full Text] [Related]
3. Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor.
Shin KY; Noh SJ; Park CH; Jeong YH; Chang KA; Yoo J; Kim HJ; Ha S; Kim HS; Park HJ; Lee JH; Moon C; Suh YH
CNS Neurol Disord Drug Targets; 2016; 15(8):935-944. PubMed ID: 27577574
[TBL] [Abstract][Full Text] [Related]
4. Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models.
Shin KY; Kim KY; Suh YH
Korean J Physiol Pharmacol; 2017 Jan; 21(1):55-64. PubMed ID: 28066141
[TBL] [Abstract][Full Text] [Related]
5. Dehydroevodiamine.HCl prevents impairment of learning and memory and neuronal loss in rat models of cognitive disturbance.
Park CH; Lee YJ; Lee SH; Choi SH; Kim HS; Jeong SJ; Kim SS; Suh YH
J Neurochem; 2000 Jan; 74(1):244-53. PubMed ID: 10617126
[TBL] [Abstract][Full Text] [Related]
6. Dehydroevodiamine·HCl Improves Stress-Induced Memory Impairments and Depression Like Behavior in Rats.
Kim HJ; Shin KY; Chang KA; Ahn S; Choi HS; Kim HS; Suh YH
Korean J Physiol Pharmacol; 2014 Feb; 18(1):55-9. PubMed ID: 24634597
[TBL] [Abstract][Full Text] [Related]
7. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
8. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model.
Cai M; Lee JH; Yang EJ
J Neuroinflammation; 2019 Dec; 16(1):264. PubMed ID: 31836020
[TBL] [Abstract][Full Text] [Related]
9. Treatment with a brain-selective prodrug of 17β-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-κB pathway.
Yan W; Wu J; Song B; Luo Q; Xu Y
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):879-886. PubMed ID: 30879099
[TBL] [Abstract][Full Text] [Related]
10. Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa.
Park CH; Kim SH; Choi W; Lee YJ; Kim JS; Kang SS; Suh YH
Planta Med; 1996 Oct; 62(5):405-9. PubMed ID: 8923803
[TBL] [Abstract][Full Text] [Related]
11. Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer's disease.
Hullmann M; Albrecht C; van Berlo D; Gerlofs-Nijland ME; Wahle T; Boots AW; Krutmann J; Cassee FR; Bayer TA; Schins RPF
Part Fibre Toxicol; 2017 Aug; 14(1):35. PubMed ID: 28854940
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatments with a 5-HT
Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
[TBL] [Abstract][Full Text] [Related]
13. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
Giralt A; de Pins B; Cifuentes-Díaz C; López-Molina L; Farah AT; Tible M; Deramecourt V; Arold ST; Ginés S; Hugon J; Girault JA
Exp Neurol; 2018 Sep; 307():62-73. PubMed ID: 29803828
[TBL] [Abstract][Full Text] [Related]
14. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
15. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
[TBL] [Abstract][Full Text] [Related]
16. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
17. Dehydroevodiamine attenuates calyculin A-induced tau hyperphosphorylation in rat brain slices.
Fang J; Liu R; Tian Q; Hong XP; Wang SH; Cao FY; Pan XP; Wang JZ
Acta Pharmacol Sin; 2007 Nov; 28(11):1717-23. PubMed ID: 17959021
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
Nakagawa T; Hasegawa Y; Uekawa K; Kim-Mitsuyama S
Exp Gerontol; 2017 Jan; 87(Pt A):108-112. PubMed ID: 27916702
[TBL] [Abstract][Full Text] [Related]
19. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
20. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
